LOXL2 Status Correlates with Tumor Stage and Regulates Integrin Levels to Promote Tumor Progression in c
Mikami N, Sueda K, Ogitani Y, Otani I, Takatsuji M, Wada Y, Watanabe K, Yoshikawa R, Nishioka
S, Hashimoto N, Miyagi Y, Fukada S, Yamamoto H, Tsujikawa K.
Calcitonin Gene-Related Peptide Regulates Type IV Hypersensitivity through Dendritic Cell
Functions.
PLoS One. 9(1): e86367. (2014)
Nakao S, Mabuchi M, Shimizu T, Itoh Y, Takeuchi Y, Ueda M, Mizuno H, Shigi N, Ohshio I,
Jinguji K, Ueda Y, Yamamoto M, Furukawa T, Aoki S, Tsujikawa K, Tanaka A.
Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as
anti-prostate cancer drugs.
Bioorg Med Chem Lett. 24: 1071-4. (2014)
Minami K, Kamijo Y, Nishizawa Y, Tabata S, Horikuchi F, Yamamoto M, Kawahara K,Shinsato Y, Tachiwada T, Chen ZS, Tsujikawa K, Nakagawa M, Seki N, Akiyama S, Arima K, Takeda Y, Furukawa T.
Expression of ABCB6 Is Related to Resistance to 5-FU, SN-38 and Vincristine.
Anticancer Res. 34, 4767-73 (2014)
Kurashige C, Hosono K, Matsuda H, Tsujikawa K, Okamoto H, Majima M.
Roles of receptor activity-modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice.
FASEB J. 28, 1237-47 (2014)
Hase H, Jingushi K, Ueda Y, Kitae K, Egawa H, Ohshio I, Kawakami R, Kashiwagi Y,Tsukada Y, Kobayashi T, Nakata W, Fujita K, Uemura M, Nonomura N, Tsujikawa K
Mol. Cancer Res. 12(12):1807-17 (2014)